The intestinal microbiome shapes responses to the GD2/GD3 cancer vaccine in children with high-risk neuroblastoma

The intestinal microbiome influences vaccine responses, but its role in therapeutic cancer vaccination remains largely unexplored. We investigated the gut microbiome, vaccine immunogenicity and clinical outcomes in 137 children with high-risk neuroblastoma receiving GD2/GD3 vaccination with oral b-glucan. Microbiome-perturbing antibiotic exposure was associated with inferior progression-free survival (PFS). Among patients vaccinated in first remission, higher a-diversity and enrichment of Lachnospiraceae, including Blautia, were associated with higher anti-GD2 IgG1 responses, while higher Clostridia abundance was associated with superior PFS. Patients had microbiome profiles resembling those of chronologically younger healthy children, consistent with delayed microbiome maturation. A greater discrepancy between patients' chronological age and the age of microbiome-matched healthy children was associated with inferior PFS among patients in first remission. In a complementary mouse model, antibiotic treatment impaired vaccine-induced anti-GD2 IgG responses and accelerated tumor growth. Together, these findings support a role for the intestinal microbiome in therapeutic cancer vaccine responses and identify microbiome maturation as a clinically relevant feature in pediatrics.

Authors

Institutions

Publication Details

Journal
bioRxiv (Cold Spring Harbor Laboratory)
Published
2026-11-17
DOI
https://doi.org/10.64898/2026.11.16.766479
Primary Topic
Gut microbiota and health
Type
preprint

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

The intestinal microbiome shapes responses to the GD2/GD3 cancer vaccine in children with high-risk neuroblastoma

Jaap Jan Boelens, Marcel R.M. van den Brink, Gretchen E. Diehl, Leena Babiker et al.
2 links
bioRxiv (Cold Spring Harbor Laboratory)
Gut microbiota and health
preprint

The intestinal microbiome shapes responses to the GD2/GD3 cancer vaccine in children with high-risk neuroblastoma

Jaap Jan Boelens, Marcel R.M. van den Brink, Gretchen E. Diehl, Leena Babiker, Oriana Miltiadous, Nai‐Kong V. Cheung, Ying Taur, Jonathan U. Peled, Brian H. Kushner, Ivan P. Maillard, Chi L. Nguyen, Kristen Victor, Nicholas R. Waters, Lanying Ma, Kate Ann Markey, Irene Y. Cheung, Katlyn Lederer, Stefan Nierkens, Kimon V. Argyropoulos, Kanaka Dhuri, Teng Fei, Shakeel I. Modak, Yunlin Zhang, Stephen R. Roberts, Nadia Brijmohan, Leana Harford, Xiaohong Wu, Anqi Dai, Ragupathi Govind, Alan Hanash, Marina da Silva, Jianmin Yang
preprint en

Abstract

The intestinal microbiome influences vaccine responses, but its role in therapeutic cancer vaccination remains largely unexplored. We investigated the gut microbiome, vaccine immunogenicity and clinical outcomes in 137 children with high-risk neuroblastoma receiving GD2/GD3 vaccination with oral b-glucan. Microbiome-perturbing antibiotic exposure was associated with inferior progression-free survival (PFS). Among patients vaccinated in first remission, higher a-diversity and enrichment of Lachnospiraceae, including Blautia, were associated with higher anti-GD2 IgG1 responses, while higher Clostridia abundance was associated with superior PFS. Patients had microbiome profiles resembling those of chronologically younger healthy children, consistent with delayed microbiome maturation. A greater discrepancy between patients' chronological age and the age of microbiome-matched healthy children was associated with inferior PFS among patients in first remission. In a complementary mouse model, antibiotic treatment impaired vaccine-induced anti-GD2 IgG responses and accelerated tumor growth. Together, these findings support a role for the intestinal microbiome in therapeutic cancer vaccine responses and identify microbiome maturation as a clinically relevant feature in pediatrics.

bioRxiv (Cold Spring Harbor Laboratory)
City Of Hope National Medical Center (US), Memorial Sloan Kettering Cancer Center (US), Fred Hutch Cancer Center (US), City of Hope (US), Princess Máxima Center (NL), Doernbecher Children's Hospital (US)
Damon Runyon Cancer Research Foundation, Rally Foundation, St. Jude Children's Research Hospital, Hyundai Hope On Wheels
Good health and well-being
Gut microbiota and health
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon